Avoro Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,035,000
| Closed | -$281M | – | 41 |
|
|
2024
Q2 | $281M | Sell |
3,035,000
-1,265,000
| -29% | -$117M | 3.75% | 10 |
|
|
2024
Q1 | $408M | Sell |
4,300,000
-144,444
| -3% | -$13.7M | 4.76% | 8 |
|
|
2023
Q4 | $397M | Buy |
+4,444,444
| New | +$397M | 5.48% | 8 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 45 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 39 |
|
|
2022
Q3 | – | Sell |
-900,000
| Closed | -$66.8M | – | 40 |
|
|
2022
Q2 | $66.8M | Sell |
900,000
-2,150,000
| -70% | -$160M | 1.32% | 19 |
|
|
2022
Q1 | $274M | Buy |
3,050,000
+2,000,000
| +190% | +$180M | 5% | 6 |
|
|
2021
Q4 | $118M | Buy |
+1,050,000
| New | +$118M | 2% | 15 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 38 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 35 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 44 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 47 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 54 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 56 |
|